drugset / Trial / NCT06747949
A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)
NaSingle-groupOpen-labelTreatment
Summary
The primary objective of this study is to evaluate the long-term safety and tolerability of dazodalibep.
Timeline
- Start
- 2025-02-25
- Primary completion
- 2029-12-11
- Completion
- 2029-12-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dazodalibep | Protein / enzyme biologic | — | Intravenous |